ReviewCellular and molecular events in corneal wound healing: significance of lipid signalling
Introduction
Lipids were regarded for many years merely as structural components of cell membranes whose main function was to regulate membrane permeability. Today, it is known that lipids form specific domains in membranes and play important roles as second messengers in cell signal transduction. They are involved in cell proliferation, migration, and survival, as well as in inflammation and angiogenesis.
Phospholipids are the basic building blocks of cell membranes and the substrates for production of lipid second messengers. They contain a glycerol backbone, a polar phosphate group attached to the third carbon, and an acyl, alkyl, or alkenyl group attached to the sn-1 and sn-2 positions. The possible combinations of the phosphate group attached to different bases (e.g. choline, ethanolamine, serine, inositol), the acyl (or other) groups at C1 and C2, and the degree of unsaturation give rise to hundreds of different lipid species in a cell. This allows for the formation of lipid rafts and specific lipid–protein interactions. The diverse roles of lipids in cell function and disease that have been discovered have renewed interest in these molecules and aided the development of new and sophisticated methods to determine changes in their composition, launching the new era of ‘lipidomics’ (Forrester et al., 2004).
The cornea is one of the simplest and, at the same time, most fascinating, tissues. It is composed mainly of three different cell layers: the epithelium, composed of 5–6 layers of cells that are very actively proliferating; the stroma, the thickest layer, with its amazing collagen organization in which are embedded the nearly quiescent keratocytes; and the endothelial monolayer, with its important pump systems to regulate the entry of substances from the aqueous humor. Corneal tissue is devoid of vascular elements; therefore, its use in research allows investigators to design experiments that need not accommodate the actions of the vascular cellular components. This simpler structure has allowed us to pose questions that are difficult to answer in more complicated systems (e.g. the nervous system). The first corneal response to injury is the very complex process of inflammation. The outcome of this response has consequences insofar as the integrity and transparency of the tissue. In the avascular cornea, inflammation is characterized by stromal cell infiltration, mainly of polymorphonuclear leukocytes (PMNs) that arrive from the limbal vessels (Paterson et al., 1984, Pfister et al., 1988). These cells are activated and generate a number of bioactive lipids that contribute to the propagation of the response (Leibowitz and Frangie, 1998). I became interested in the significance of lipid mediators in the cornea after injury in the early 1980s, and this review concentrates mainly on the work done in my laboratory on this subject. Papers or reviews that are relevant to some aspects of this discussion are cited, but this is not intended to be a comprehensive review of all the literature on the subject. Space constraints prevent me from quoting all relevant contributions.
Section snippets
Corneal injury induces the release of arachidonic acid and its conversion to eicosanoids: cellular specificity
Being trained in lipid biochemistry, my first project was to determine the lipid composition of the three layers of the cornea, specifically, the fatty acid composition of membrane lipids. There were, at that time, some reports on the composition of phospholipids and their accumulation during aging and in corneas with granular dystrophies (Feldman, 1967, Broekhuyse, 1968, Rodrigues et al., 1983), but overall there was very little information about fatty acid composition or corneal lipid
Selective growth factor signalling in corneal epithelial cell proliferation is mediated by 12/15(S)-HETEs
Lipoxygenases are enzymes that produce fatty acid hydroxyperoxides by introducing oxygen at different positions along the carbon chain of fatty acids, mainly AA, to form the 5(S)-, 12(S)-, and 15(S)-hydroxyperoxides. These compounds are then rapidly reduced to the corresponding HETES (Fig. 1). The enzymes involved in these conversions are 5-lipoxygenase (5-LOX), 12-LOX, and 15-LOX, which are strongly expressed in leukocytes, platelets, and reticulocytes, respectively, but selective expression
Docosahexaenoic acid and its bioactive products as neuroprotective agents
Injury to the cornea produces damage to corneal nerves, and as a consequence, adverse effects occur, such as delayed wound healing, desiccation of the corneal surface, and alterations in epithelial cell metabolism (for review, see Muller et al., 2003).
Docosahexahenoic acid (DHA) is a polyunsaturated fatty acid with six double bonds that belongs to the omega-3 fatty acid family (Fig. 1). DHA is required for neuronal and retinal photoreceptor functions (for review, see Bazan, 2003). Recently, the
PAF is a key mediator of the inflammatory response that delays corneal wound healing
Another very active lipid in the cornea is PAF (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) (Fig. 1). PAF is synthesized by many types of stimulated cells, and due to its potent actions, has been implicated in the pathogenesis of a variety of diseases (Zimmerman et al., 1996, Zimmerman et al., 2002). It can cause microvascular leakage, vasodilation, and activation of several types of inflammatory cells, such as neutrophils, eosinophils, and macrophages. In cornea, PAF stimulates several
Modulation of corneal extracellular matrix remodelling by PAF
One of the most important mechanisms by which PAF delays epithelial wound closure is by activating, at the transcriptional level, the expression of selective metalloproteinases (MMPs) and urokinase plasminogen activator (uPA) in the cornea (Bazan et al., 1993, Tao et al., 1995, Tao et al., 1996; Fig. 1). The normal process of corneal repair requires degradation and re-synthesis of components of the ECM, such as different types of collagens, gelatins, laminin, and fibronectin.
PAF promotes corneal neovascularization
Slow-release pellets containing PAF implanted in mouse cornea induce a strong angiogenic response. Corneal vessels reaching the micropocket were seen 6 days after implantation (Ma et al., 2004). The PAF-induced neovascularization was significantly reduced in PAF-R-knockout mice and in animals treated with a PAF antagonist. In two types of vascular endothelial cells, human umbilical cord vein endothelial cells (HUVEC) and human dermal microvascular endothelial cells (HMVEC), PAF stimulates cell
PAF activates corneal myofibroblasts' ability to modulate the extracellular matrix
Recent findings that corneal myofibroblasts express the PAF-R (He and Bazan, 2003) led us to investigate what role(s) PAF has in these cells. While stromal keratocytes are nearly quiescent cells that contribute to the maintenance of tissue transparency, myofibroblasts express α-smooth muscle actin (α-SM-actin) and are involved in the contraction of corneal wounds (Jester et al., 1999). PAF induces apoptosis of keratocytes 4 hr after stimulation (Chandrasekher et al., 2002); in contrast,
PAF antagonists inhibit diffuse lamellar keratitis and chemical-induced corneal perforation
The wide variety of responses induced by PAF points toward a central role played by this inflammatory mediator in cornea following pathologic stimulus. Inhibition of the PAF-R is an approach that could attenuate the inflammatory cascade at its initial steps and be beneficial in maintaining the integrity of the tissue (Fig. 2). Several PAF antagonists have been developed and tested for efficacy in different pathologic conditions in the eye as well as in many other tissues (Zimmerman et al., 1996
Conclusions
Here, we have summarized some of the physiological and pathological roles of bioactive lipids in cornea after injury. Inflammation is the first response of corneal tissue to an insult, and during the first hours, the cells of the corneal layers respond by releasing AA from membrane phospholipids and converting this fatty acid into eicosanoids and PAF. If inflammation is more severe and persists, cells that infiltrate the cornea, mainly neutrophils, amplify the response and contribute to the
Acknowledgements
The author's research was supported by United States Public Health Service grants R01 EY04928 and R01 EY06635 from the National Eye Institute, National Institutes of Health, Bethesda, MD.
References (97)
- et al.
Differential expression of cyclooxygenase-1 and cyclooxygenase-2 in the cornea during wound healing
Tissue Cell
(2004) Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activaving factor
J. Lipid Res.
(2003)- et al.
The role of platelet-activating factor in the corneal response to injury
Prog. Retin. Eye Res.
(2002) - et al.
Platelet-activating factor (PAF) accumulation correlates with injury in the cornea
Exp. Eye Res.
(1991) - et al.
Neuronal basis of sensation in intact and injured corneas
Exp. Eye Res.
(2004) Phospholipids in tissues of the eye I. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids
Biochim. Biophys. Acta
(1968)- et al.
Selective changes in protein kinase C (PKC) isoform expression in rabbit corneal epithelium during wound healing. Inhibition of corneal epithelial repair by PKCalpha antisense
Exp. Eye Res.
(1998) - et al.
Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist
J. Cataract Refract. Surg.
(2004) - et al.
Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat
Exp. Eye Res.
(1993) - et al.
Diffuse lamellar keratitis: evaluation of etiology, histopathologic findings, and clinical implications in an experimental animal model
J. Cataract Refract. Surg.
(2003)
Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor
Exp. Eye Res.
The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury
J. Biol. Chem.
Platelet-activating factor receptor: gene expression and signal transduction
Biochim. Biophys. Acta
Corneal stromal wound healing in refractive surgery: the role of myofibroblasts
Prog. Retin. Eye Res.
Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2
J. Biol. Chem.
Novel membrane target proteins for lipoxygenase-derived mono(S)hydroxy fatty acids
Biochim. Biophys. Acta
Lipoxygenases in corneal epithelia of man and cynomolgus monkey
Exp. Eye Res.
cPLA2 is phosphorylated and activated by MAP kinase
Cell
Corneal nerves: structure, contenet and function
Exp. Eye Res.
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
J. Biol. Chem.
Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2
Exp. Eye Res.
Growth factor-induced proliferation in corneal epithelial cells is mediated by 12(S)-HETE
Exp. Eye Res.
Characteristics of polymorphonuclear leukocytes infiltration into the alkali burned eye and the influence of sodium citrate
Exp. Eye Res.
Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)
FEBS Lett.
15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa
J. Invest. Dermatol.
MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology
Prog. Retin. Eye Res.
Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding
Exp. Eye Res.
Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration
FASEB J.
Corneal injury alters eicosanoid formation in the rabbit anterior segment in vivo
Invest. Ophthalmol. Vis. Sci.
Composition of phospholipids and free fatty acids and incorporation of labeled arachidonic acid in rabbit cornea. Comparison of epithelium, stroma and endothelium
Curr. Eye Res.
PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration
J. Ocul. Pharmacol. Ther.
A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet activating factor (PAF) in corneal epithelium
Curr. Eye Res.
Cryogenic lesion alters the metabolism of arachidonic acid in rabbit cornea layers
Invest. Ophthalmol. Vis. Sci.
Inflammation-induced stimulation of the synthesis of prostaglandins and lipoxygenase-reaction products in rabbit cornea
Curr. Eye Res.
Platelet-activating factor induces collagenase expression in corneal epithelial cells
Proc. Natl Acad. Sci. USA
Platelet-activating factor antagonists and ocular inflammation
J. Ocul. Pharmacol.
Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway
Invest. Ophthalmol. Vis. Sci.
Arachidonic and lipoxygenease products in ocular tissues and their effect on leukocyte infiltration in vivo
Proc. Int. Soc. Eye Res.
Discovery of a second 15S-lipoxygenase in humans
Proc. Natl Acad. Sci. USA
Lipid mediators in the pathophysiology of critical illness
Crit. Care Med.
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression
Proc. Natl Acad. Sci. USA
Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor
Invest. Ophthalmol. Vis. Sci.
Expression and subcellular localization of lipoxygenases in human corneal epithelial cells
Invest. Ophthalmol. Vis. Sci.
Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation
Invest. Ophthalmol. Vis. Sci.
Release of prostaglandins in ocular inflammation
Nature
Swelling in the isolated perfused cornea induced by 12(R)hydroxyeicosatetraenoic acid
Invest. Ophthalmol. Vis. Sci.
Ginkgo biloba extract for age-related macular degeneration
Cochrane Database Syst. Rev.
Cited by (57)
Corneal gene therapy: Structural and mechanistic understanding
2023, Ocular SurfaceClinical significance of phospholipase A2 in glaucoma
2023, Phospholipases in Physiology and Pathology: Volumes 1-7Omega-3 polyunsaturated fatty acids and corneal nerve health: Current evidence and future directions
2023, Ocular SurfaceCitation Excerpt :Omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) are key components of cellular phospholipid membranes and are essential for maintaining cell function. Within the body, omega-3 PUFAs and their metabolic by-products impart a range of biological effects, including reducing systemic inflammation and influencing neuronal function [14,15]. The anti-inflammatory effects of omega-3 PUFAs on the ocular surface are relatively well known.
Platelet activating factor in the eye: Physiological roles, diseases and future perspectives
2021, Prostaglandins and Other Lipid MediatorsCitation Excerpt :PAFR was found expressed in choroidal tissue, indicating its important role in blood vessel maintenance [8]. PAF is known to play an important role in the neovascularization process (Fig. 3D) [95]. It has been shown that PAF stimulated human umbilical cord vein endothelial cell (HUVEC) migration, by increasing the expression of vascular endothelial growth factor (VEGF), an essential factor for differentiation, morphogenesis, and homeostasis of blood vessels [96].
Lipidomic analysis of human corneal epithelial cells exposed to ocular irritants highlights the role of phospholipid and sphingolipid metabolisms in detergent toxicity mechanisms
2020, BiochimieCitation Excerpt :Sphingolipids (SL) are also well-known bioactive lipid species that induce the release of pro-inflammatory cytokines such as IL-1β and activate caspase 3 resulting in cell apoptosis [27,28]. Perturbation of lipid metabolism has been previously described in corneal alteration [29–31]. Dysregulation of SL metabolism, especially ceramide species, play a key role in corneal injury due to nitrogen mustard exposure [32].